KRAS and carcinoma: The relationship between borderline ovarian tumors and low-grade carcinomas has been investigated at the gene level by many groups [26-28] focusing on the mutually exclusive mutations detected in either the BRAF or KRAS gene, and a relationship was found between the two groups of tumors.